Lishuo Shi

1.4k total citations · 1 hit paper
39 papers, 496 citations indexed

About

Lishuo Shi is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lishuo Shi has authored 39 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lishuo Shi's work include Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Inflammatory Bowel Disease (5 papers). Lishuo Shi is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Inflammatory Bowel Disease (5 papers). Lishuo Shi collaborates with scholars based in China, Australia and United States. Lishuo Shi's co-authors include Yumo Xie, Yanxin Luo, Xiaosheng He, Wen Chen, Li Ling, André M. N. Renzaho, Brian J. Hall, Yuanbo Liang, Charles E. Protzman and D.F. Woodward and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lishuo Shi

29 papers receiving 490 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gastrointestinal cancers in China, the USA, and Europe

2021 148 citations Lishuo Shi et al. profile →

Peers

Lishuo Shi

ONCOL

PHARM

SURGE

Jianqiang Hao United States

Christopher Kaiser United States

Greg Anglin United States

Dae-Sung Hyun South Korea

Junko Honda Japan

Susanne Voelter‐Mahlknecht Germany

Patricia L. Dill United States

Kaori Wada Japan

Andrea Sbrana Italy

Tiberiu Bratu Romania

Jianqiang Hao United States

Lishuo Shi

117 ×1.0

ONCOL

48 ×0.5

59 ×0.7

PHARM

186 ×2.2

SURGE

54 ×0.8

Citations per year, relative to Lishuo Shi Lishuo Shi (= 1×) peers Jianqiang Hao

Countries citing papers authored by Lishuo Shi

Since Specialization

Citations

This map shows the geographic impact of Lishuo Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lishuo Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lishuo Shi more than expected).

Fields of papers citing papers by Lishuo Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lishuo Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lishuo Shi. The network helps show where Lishuo Shi may publish in the future.

Co-authorship network of co-authors of Lishuo Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Lishuo Shi. A scholar is included among the top collaborators of Lishuo Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lishuo Shi. Lishuo Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Zicheng, Na Diao, Miao Li, et al.. (2025). Comparative Effectiveness of Infliximab vs Ustekinumab for Endoscopic and Transmural Remission in Biologic Naïve Crohn’s Disease. Clinical Gastroenterology and Hepatology. 24(1). 172–180.

Zheng, Han, Nian Liu, Tianhua Zhou, et al.. (2025). Rapidly dissolving and detachable microneedles loaded with antimicrobial peptides for acne vulgaris treatment. Journal of Materials Chemistry B. 13(46). 15077–15089.

Chen, Lihong, et al.. (2025). Correlation between the Observer's Assessment of Alertness/Sedation score and bispectral index in patients receiving propofol titration during general anesthesia induction.. PubMed. 45(1). 52–58. 1 indexed citations

Yang, Tao, Ji Qi, Xinyi Lin, et al.. (2025). Short-term outcomes of endoscopic intermuscular dissection for early rectal cancer with deep submucosal infiltration: a single-center experience from China. Techniques in Coloproctology. 29(1). 191–191.

Xie, Peiyi, Qitong Huang, Li Zheng, et al.. (2024). Sub-region based histogram analysis of amide proton transfer-weighted MRI for predicting tumor budding grade in rectal adenocarcinoma: a prospective study. European Radiology. 35(3). 1382–1393. 4 indexed citations

Li, Yingru, Xiaochuang Feng, Yu Zhang, et al.. (2024). Impact of three‐dimensional–printing technology guidance on surgical outcomes for retroperitoneal sarcoma: A propensity score‐matched study. Cancer. 131(1). e35452–e35452. 1 indexed citations

Xia, Huilong, Yi‐Xin Zeng, Lishuo Shi, et al.. (2024). Impacts of pharmacist-led multi-faceted antimicrobial stewardship on antibiotic use and clinical outcomes in urology department of a tertiary hospital in Guangzhou, China: an interrupted time-series study. Journal of Hospital Infection. 151. 148–160. 1 indexed citations

Wu, Zehua, Jianxia Li, Chao Wang, et al.. (2024). PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial. Med. 5(8). 998–1015.e6. 7 indexed citations

Yao, Qijun, Wan He, Yandong Zhao, et al.. (2024). PD-1 blockade combined with chemotherapy and bevacizumab in DNA mismatch repair-proficient/microsatellite stable colorectal liver metastases. Journal of Gastrointestinal Oncology. 15(4). 1534–1544. 1 indexed citations

10.

Yang, Hongsheng, Miao Li, Haiyan Zhang, et al.. (2023). Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-naïve or anti-TNF-exposed Crohn's disease: a multicenter cohort study. EClinicalMedicine. 66. 102337–102337. 13 indexed citations

11.

Hu, Huabin, Lishuo Shi, Jie Zhou, et al.. (2023). China special issue on gastrointestinal tumors‐Radiological features of pathological complete response in mismatch repair deficient colorectal cancer after neoadjuvant PD‐1 blockade: A post hoc analysis of the PICC phase II trial. International Journal of Cancer. 153(11). 1894–1903. 3 indexed citations

12.

Ling, Jiayu, Lishuo Shi, Yandong Zhao, et al.. (2023). Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor. Journal of Gastrointestinal Oncology. 14(1). 73–84.

13.

Wu, Zehua, Lishuo Shi, Jianwei Zhang, et al.. (2022). Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial. EClinicalMedicine. 49. 101480–101480. 4 indexed citations

14.

Zhang, Hui, et al.. (2022). Association between migration paths and mental health of new-generation migrants in China: The mediating effect of social integration. Frontiers in Psychiatry. 13. 967291–967291. 9 indexed citations

15.

Shi, Lishuo, Wen Chen, Peizhen Zhao, et al.. (2021). Spatiotemporal distribution and sociodemographic and socioeconomic factors associated with primary and secondary syphilis in Guangdong, China, 2005–2017. PLoS neglected tropical diseases. 15(8). e0009621–e0009621. 11 indexed citations

16.

Deng, Yanhong, Lishuo Shi, Jianxia Li, et al.. (2021). The Trends of Psychological Status of People Entering from High-Risk Areas of COVID-19 Coronavirus During the Quarantine in Dedicated Hotels: A Longitudinal Survey Study from Guangzhou, China. Risk Management and Healthcare Policy. Volume 14. 5005–5014. 2 indexed citations

17.

Renzaho, André M. N., et al.. (2020). Time-varying associations of pre-migration and post-migration stressors in refugees' mental health during resettlement: a longitudinal study in Australia. The Lancet Psychiatry. 8(1). 36–47. 66 indexed citations

18.

Zhang, Hui, et al.. (2019). Migration status and healthcare seeking behaviours among the Chinese labor-force: a nationally representative study. BMJ Open. 9(11). e031798–e031798. 12 indexed citations

19.

Shi, Lishuo, et al.. (2019). Impact of acculturation and psychological adjustment on mental health among migrant adolescents in Guangzhou, China: a cross-sectional questionnaire study. BMJ Open. 9(5). e022712–e022712. 28 indexed citations

20.

Matias, Isabel, Luciano De Petrocellis, Tiziana Bisogno, et al.. (2004). Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism. Journal of Pharmacology and Experimental Therapeutics. 309(2). 745–757. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact